AGER p.Gly82Ser

Variant summary

Our verdict is Benign.
-7 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -7 classification points (ACMG Germline Pathogenicity v2019). BA1PP3

The NM_001136.5(AGER):c.244G>A (p.Gly82Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0561 (AC=90,557) in the gnomAD database across 1,613,010 control chromosomes, including 3,365 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.196. In-silico predictor (REVEL) classifies this variant as likely benign. Variant has been reported in ClinVar as Uncertain Significance (no review stars). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.039 ( 234 hom., cov: 33)
Exomes 𝑓: 0.058 ( 3131 hom. )

Consequence

AGER
NM_001136.5 missense

Scores

2
4
12

Clinical Significance

Uncertain significance no assertion criteria provided U:1

Conservation

PhyloP100: 2.46

Publications

239 publications found
Variant links:
Genes affected
AGER (HGNC:320): (advanced glycosylation end-product specific receptor) The advanced glycosylation end product (AGE) receptor encoded by this gene is a member of the immunoglobulin superfamily of cell surface receptors. It is a multiligand receptor, and besides AGE, interacts with other molecules implicated in homeostasis, development, and inflammation, and certain diseases, such as diabetes and Alzheimer's disease. Many alternatively spliced transcript variants encoding different isoforms, as well as non-protein-coding variants, have been described for this gene (PMID:18089847). [provided by RefSeq, May 2011]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001136.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -7 points.

PP3Computational evidence supports damaging effect
Splicing predictors (SpliceAI/dbscSNV) support splicing impact — supporting computational evidence (PP3); Splicing verdict: pathogenic (Supporting).; Germline computational verdict: not pathogenic.
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.1958 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001136.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

AGER NM_001136.5
MANE Select
HGVSc / HGVSpc.244G>Ap.Gly82Ser
Exon rankExon 3 of 11
missense
Prot: NP_001127.1UniProt: Q15109-1
AGER NM_001206929.2
HGVSc / HGVSpc.244G>Ap.Gly82Ser
Exon rankExon 3 of 11
missense
Prot: NP_001193858.1UniProt: Q15109-6
AGER NM_001206932.2
HGVSc / HGVSpc.202G>Ap.Gly68Ser
Exon rankExon 3 of 11
missense
Prot: NP_001193861.1UniProt: Q15109-7

Ensembl Transcripts

AGER ENST00000375076.9
TSL:1MANE Select
HGVSc / HGVSpc.244G>Ap.Gly82Ser
Exon rankExon 3 of 11
missense
Prot: ENSP00000364217.4UniProt: Q15109-1
AGER ENST00000375069.7
TSL:1
HGVSc / HGVSpc.244G>Ap.Gly82Ser
Exon rankExon 3 of 11
missense
Prot: ENSP00000364210.4UniProt: Q15109-6
AGER ENST00000438221.6
TSL:1
HGVSc / HGVSpc.244G>Ap.Gly82Ser
Exon rankExon 3 of 10
missense
Prot: ENSP00000387887.2UniProt: Q15109-4

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.0388
AC:5905
Hom:234
AN:152132
Cov:33
GnomAD2 exomes
AF: 0.0532
AC:13091
AN:245924
GnomAD4 exome
AF: 0.0580
AC:84662
Hom:3131
AN:1460760
Cov:36
GnomAD4 genome
AF: 0.0387
AC:5895
Hom:234
AN:152250
Cov:33
TOPMed (Bravo)
AF: 0.0339
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0429
AC:22085
Hom:767
AN:515214
Local & regional cohorts 9 sources
ABraOM SABE-WGS-1171
AF: 0.0179
AC:42
Hom:1
AN:2342
ESP6500 (Exome Variant Server)
AF: 0.0349
AC:294
AN:8430
GenomeAsia100K
AF: 0.104
AC:361
AN:3478
Korea4K (4,157 Koreans)
AF: 0.159
AC:1149
AN:7234
Qatari Genome
AF: 0.0204
AC:41
AN:2010
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.153
AC:18670
Hom:1442
AN:122192
Turkish Variome
AF: 0.0395
AC:61
Hom:2
AN:1546
UK10K
AF: 0.0731
AC:553
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.254
AC:2272
Hom:268
AN:8960
Showing 15 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.0514 *4949620 0.0484 *50510424
BipEx
(Bipolar disorder (including schizoaffective))
0.0550 156228420 0.0564 162728844
Epi25
(Epilepsy)
0.0534 224241958 0.0496 331766888
SCHEMA
(Schizophrenia)
0.0837 10740128388 0.0666 13132197070
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
COPD, severe early onset (1)

Computational Scores

AlphaGenome AVI
Pathogenic32
AlphaMissense
Benign0.31
BayesDel_addAF
Benign-0.52T
BayesDel_noAF
Benign-0.37
CADD
Pathogenic34
DANN
Uncertain1.0
DEOGEN2
Benign0.11T
Eigen
Uncertain0.67
Eigen_PC
Pathogenic0.68
FATHMM_MKL
Uncertain0.88D
FuncVEP CTI
Benign0.13
GPN-Star LLR
N/A-4.6
GPN-Star score
N/A4.6
LIST_S2
Benign0.84T
MetaRNN
Benign0.0017T
MetaSVM
Benign-1.2T
Mutation Taster
N/A87/13polymorphism (auto)
MutationAssessor
Uncertain2.8M
PhyloP100
Benign2.5
popEVE
Benign-3.8
PrimateAI
Benign0.46T
PROVEAN
Benign-1.9N
REVEL
Benign0.16
Sift
Benign0.51T
Sift4G
Pathogenic0.0D
Varity_R
N/A0.20
VESM-3B
Benign-8.2
Showing 27 of 27 scores

Splicing Scores

DS_AG_spliceai
Pathogenic0.73
Position offset: -2
Pangolin (max)
Pathogenic0.53
Pangolin gain
Pathogenic0.53
Position offset: -2
SpliceAI score (max)
Pathogenic0.73
Details are displayed if max score is > 0.2
Showing 4 of 4 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs2070600;
hg19: chr6-32151443;
COSMIC: COSV107496643;
COSMIC: COSV107496643;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.